Drug chains forge ahead amid uncertainty
It’s fair to say that the chain drug industry is at a turning point.
It’s fair to say that the chain drug industry is at a turning point.
Strategy reflects Cencora’s commitment to meet customers’ evolving needs.
While we share lawmakers’ commitment to promoting consumer safety, we believe the proposed legislation takes an overly broad approach that could inadvertently impact legitimate dietary supplements without addressing the root causes of public health concerns.
This collaboration integrates cutting-edge telemedicine technology into local pharmacies, enhancing access to primary and urgent care while reinforcing their critical role within communities.
The donation will help End Overdose distribute Padagis Naloxone to thousands of college students.
Over two hundred people attended Founders' Innovation Day, hosted by retailmediaIQ and ECRM in NYC.
The groups say that bipartisan recognition of PBMs’ detrimental practices is widespread.
The agreement has been in place since 2019 and has scored a major new product launch success in delivering a biosimilar product into the Japanese market. This biosimilar is used with cancer medicines.
In 2024, fills for Wegovy and Zepbound increased by over 100% and 300%, respectively.
In-store clinics are central to the transition, according to the report, titled “The Healthcare Opportunity in Grocery.”
The investment will benefit millions of patients worldwide, boosting the production of the company's medicines, including those for diabetes and obesity.
Revenue was hit by lower fuel prices as well as the sale of its specialty pharmacy business.
The partnership addresses the growing need for sophisticated and robust robotic pharmacy automation systems in hospitals throughout North America.
NRF's Kleinhenz: “Consumers’ perception of the economy has improved, fueling retail activity.”
NACDS reflects on achievements and impact of Nourish My Health in its first year; looks ahead to continued momentum in 2025.